Navigating the Regulatory Labyrinth: How Biotech Leaders Are Rethinking Strategy in an Uncertain Regulatory Era

Summary

Opinion piece discussing how biotech companies are adapting their strategies amid evolving regulatory uncertainty, with emphasis on rigorous program development for competitive positioning.